Victory Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-414	Closed	-$3.56K	–	2527
2025 Q1	$3.56K	Sell	414 -14	-3%	-$216	﹤0.01%	2470
2024 Q4	$15.3K	Sell	428 -30	-7%	-$1.55K	﹤0.01%	2457
2024 Q3	$21.7K	Sell	458 -17	-4%	-$750	﹤0.01%	2435
2024 Q2	$23.9K	Sell	475 -8	-2%	-$578	﹤0.01%	2420
2024 Q1	$54.1K	Sell	483 -26	-5%	-$2.58K	﹤0.01%	2369
2023 Q4	$29.5K	Buy	+509	New	+$20.5K	﹤0.01%	2480
2022 Q3	–	Sell	-501	Closed	-$58K	–	2744
2022 Q2	$58K	Buy	501 +91	+22%	+$8.56K	﹤0.01%	2535
2022 Q1	$36K	Buy	+410	New	+$47.9K	﹤0.01%	2616
2021 Q2	–	Sell	-755	Closed	-$305K	–	2796
2021 Q1	$305K	Sell	755 -427	-36%	-$207K	﹤0.01%	2388
2020 Q4	$786K	Buy	1,182 +403	+52%	+$224K	﹤0.01%	1886
2020 Q3	$362K	Buy	779 +414	+113%	+$209K	﹤0.01%	2093
2020 Q2	$213K	Sell	365 -76	-17%	-$26K	﹤0.01%	2279
2020 Q1	$64K	Buy	+441	New	+$77.1K	﹤0.01%	2669
2019 Q4	–	Sell	-258	Closed	-$10K	–	3018
2019 Q3	$10K	Buy	+258	New	+$18.8K	﹤0.01%	3260
2018 Q1	–	Sell	-2,317	Closed	-$952K	–	1880
2017 Q4	$952K	Buy	2,317 +229	+11%	+$99.9K	﹤0.01%	1231
2017 Q3	$903K	Sell	2,088 -72	-3%	-$28.4K	﹤0.01%	1230
2017 Q2	$754K	Buy	+2,160	New	+$747K	﹤0.01%	1240